Get startedLog in
    Picture of Hansa Biopharma AB logo

    HNSA — Hansa Biopharma AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapMomentum Trap
    All News

    Brief: Hansa Biopharma Signs Idefirix Licensing Deal With SERB For Europe, MENA

    Picture of Hansa Biopharma AB logoHansa Biopharma AB
    01/07/2026 14:21
    BRIEF-Hansa Biopharma Signs Idefirix Licensing Deal With SERB For Europe, MENA
    July 1 (Reuters) - Hansa Biopharma AB HNSA.ST:
    • HANSA BIOPHARMA ANNOUNCES CLOSING OF €115 MILLION LICENSING TRANSACTION WITH SERB PHARMACEUTICALS FOR IDEFIRIX IN EUROPE AND MENA 
    • DEAL INCLUDES €110 MLN UPFRONT AND €5 MLN ON EMA FILING ACCEPTANCE 
    • SERB TO ASSUME LONG-TERM PAES FOLLOW-UP AND PAEDIATRIC STUDY RESPONSIBILITY

    Source text: ID:nPn4QdJfGa
    Further company coverage: HNSA.ST

     (Gdansk Newsroom)
     ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Hansa Biopharma AB

    See all news